725240-17-5

Basic information

• Product Name: (2S)-[(2S)-benzyloxycarbonylaminopropionylamino]-5-{[(3S)-((1S)-methylpropyl)-4-oxooxetane-(2R)-carbonyl]amino}pentanoic acid benzyl ester
• Synonyms: (2S)-[(2S)-benzyloxycarbonylaminopropionylamino]-5-{[(3S)-((1S)-methylpropyl)-4-oxooxetane-(2R)-carbonyl]amino}pentanoic acid benzyl ester
• CAS NO: 725240-17-5
• Molecular Weight: 581.666
• Mol File: 725240-17-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (2S)-[(2S)-benzyloxycarbonylaminopropionylamino]-5-{[(3S)-((1S)-methylpropyl)-4-oxooxetane-(2R)-carbonyl]amino}pentanoic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-[(2S)-benzyloxycarbonylaminopropionylamino]-5-{[(3S)-((1S)-methylpropyl)-4-oxooxetane-(2R)-carbonyl]amino}pentanoic acid benzyl ester(725240-17-5)
• EPA Substance Registry System: (2S)-[(2S)-benzyloxycarbonylaminopropionylamino]-5-{[(3S)-((1S)-methylpropyl)-4-oxooxetane-(2R)-carbonyl]amino}pentanoic acid benzyl ester(725240-17-5)

Safety Data

• Hazardous Substances Data: 725240-17-5(Hazardous Substances Data)

Upstream product

• 28977-69-7 (S)-3-methylpentanoic acid chloride 
• 725240-14-2 trimethyl-[(3S)-methyl-1-phenylsulfanylpent-(1Z)-enyloxy]silane 
• 725240-13-1 (S)-3-methylpentanethioic acid S-phenyl ester 
• 873309-30-9 (2S,3S)-2-((R)-2-Benzyloxy-1-hydroxy-ethyl)-3-methyl-pentanoic acid 
• 873309-34-3 (3R,2R)-4-benzyloxy-2-((S)-sec-butyl)butane-1,3-diol 
• 873309-35-4 (3S,4R)-4-benzyloxymethyl-3-((S)-sec-butyl)oxetan-2-one 
• 873309-44-5 (2S,3S)-2-((R)-2-Benzyloxy-1-hydroxy-ethyl)-3-methyl-pentanal 
• 873309-42-3 (3S,4R)-3-((S)-sec-Butyl)-4-hydroxymethyl-oxetan-2-one 
• 936730-76-6 S-pyridin-2-yl (S)-3-methylpentanethioate 
• 936730-80-2 benzyl (5S,8S)-5-methyl-3,6,13-trioxo-1-phenyl-2-oxa-4,7,12-triazapentadec-14-ene-8-carboxylate 
• 936730-87-9 C₂₈H₃₄O₇ 
• 936730-79-9 C₁₆H₂₇ONSSi 
• 39616-77-8 (S)-3-methylvaleric acid methyl ester 
• 1730-92-3 (3S)-methylvaleric acid 

Relevant articles and documents

NOVEL BELACTOSIN DERIVATIVES AS THERAPEUTIC AGENTS/BIOLOGICAL PROBES AND THEIR SYNTHESIS

Derivatives of belactosin and their synthesis are disclosed. In certain embodiments, compounds of the present invention exhibit anti-cancer, antiviral, antibiotic, and/or autoimmune therapeutic abilities. In general, methods of synthesis disclosed herein

Stereoselective synthesis of belactosin C and its derivatives using a catalytic proline catalyzed crossed-aldol reaction

A highly practical and concise stereoselective total synthesis of belactosin C and synthetic variants was achieved using an S-proline catalyzed crossed-aldol reaction as the key step.

Enantioselective total syntheses of belactosin A, belactosin C, and its homoanalogue

Enantioselective total syntheses of belactosin A, belactosin C, and its homoanalogue have been accomplished in high overall yields (32% for belactosin A from the amino acid 10, and 35 and 36% for belactosin C and its homoanalogue, respectively). This conc